Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benfotiamine in Diabetic Nephropathy
2007-001755-19Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) comparing Benfotiamine with Placebo (2 arms). Primary endpoints: Change in urinary β2-microglobulin and albumin excretion and Change in urinary markers of renal tubulointerstitial damage and inflammation. Started Oct 2007; status: active.
02
Drugs
benfotiamine
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-001755-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001755-19.